Home/Nkarta/Paul J. Hastings

PJ

Paul J. Hastings

Chief Executive Officer & Chairman

Therapeutic Areas

Autoimmune Diseases Oncology

Nkarta Pipeline

Drug	Indication	Phase
NKX019	Lupus Nephritis	Phase 1
NKX101	Acute Myeloid Leukemia / Higher-Risk MDS	Phase 1

Leadership Team at Nkarta

James R. Trager, Ph.D.

Chief Scientific Officer

David R. Shook, M.D.

Chief Medical Officer

Nigel R. Parker, CPA

Chief Financial Officer

Andrea van Elsas, Ph.D.

Chief Scientific Officer, Autoimmune

Randy G. Robinson

Chief Commercial Officer, Autoimmune

View full Nkarta profile